New cancer clinical trial: [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Published on: May 28, 2018 at 12:00PM
Conditions:   Healthy Subject;   Intracranial Neoplasm;   Recurrent Glioblastoma
Interventions:   Drug: Fluorine F 18 DASA-23;   Procedure: Positron Emission Tomography
Sponsor:   Sanjiv Sam Gambhir
Recruiting
https://ift.tt/2JcmhJL